galantamine and Anorexia

galantamine has been researched along with Anorexia in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Algharably, EEA; Bermpohl, F; Bittner, N; Brandl, EJ; Funk, CSM; Kreutz, R; Riemer, TG; Schmidt, A	1
Gallini, A; Montastruc, JL; Salandini, AM; Sommet, A; Veyssière, P	1

Reviews

1 review(s) available for galantamine and Anorexia

Article	Year
Psychiatric Adverse Events of Acetylcholinesterase Inhibitors in Alzheimer's Disease and Parkinson's Dementia: Systematic Review and Meta-Analysis. Drugs & aging, 2023, Volume: 40, Issue:11 Topics: Acetylcholinesterase; Alzheimer Disease; Anorexia; Cholinesterase Inhibitors; Donepezil; Galantamine; Humans; Parkinson Disease; Phenylcarbamates; Randomized Controlled Trials as Topic; Rivastigmine; Sleep Initiation and Maintenance Disorders	2023

Article

Year

Psychiatric Adverse Events of Acetylcholinesterase Inhibitors in Alzheimer's Disease and Parkinson's Dementia: Systematic Review and Meta-Analysis.

Drugs & aging, 2023, Volume: 40, Issue:11

Topics: Acetylcholinesterase; Alzheimer Disease; Anorexia; Cholinesterase Inhibitors; Donepezil; Galantamine; Humans; Parkinson Disease; Phenylcarbamates; Randomized Controlled Trials as Topic; Rivastigmine; Sleep Initiation and Maintenance Disorders

2023

Other Studies

1 other study(ies) available for galantamine and Anorexia

Article	Year
Weight-loss associated with anti-dementia drugs in a patient with Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2007, Oct-15, Volume: 22, Issue:13 Topics: Adverse Drug Reaction Reporting Systems; Aged; Anorexia; Antiparkinson Agents; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Galantamine; Humans; Lewy Body Disease; Memantine; Mental Status Schedule; Nausea; Nootropic Agents; Parkinson Disease; Vomiting; Weight Loss	2007

Article

Year

Weight-loss associated with anti-dementia drugs in a patient with Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society, 2007, Oct-15, Volume: 22, Issue:13

Topics: Adverse Drug Reaction Reporting Systems; Aged; Anorexia; Antiparkinson Agents; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Galantamine; Humans; Lewy Body Disease; Memantine; Mental Status Schedule; Nausea; Nootropic Agents; Parkinson Disease; Vomiting; Weight Loss

2007